GC
Globeflex Capital’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.47M | Buy |
298,087
+43,901
| +17% | +$953K | 0.54% | 43 |
|
|
2025
Q1 | $6.16M | Buy |
254,186
+59,400
| +30% | +$1.44M | 0.57% | 40 |
|
|
2024
Q4 | $4.07M | Buy |
194,786
+148,388
| +320% | +$3.1M | 0.34% | 72 |
|
|
2024
Q3 | $922K | Sell |
46,398
-182,386
| -80% | -$3.63M | 0.09% | 193 |
|
|
2024
Q2 | $3.54M | Hold |
228,784
| – | – | 0.37% | 65 |
|
|
2024
Q1 | $3.65M | Hold |
228,784
| – | – | 0.36% | 63 |
|
|
2023
Q4 | $3.85M | Sell |
228,784
-5,500
| -2% | -$92.5K | 0.39% | 64 |
|
|
2023
Q3 | $2.74M | Sell |
234,284
-62,212
| -21% | -$727K | 0.32% | 82 |
|
|
2023
Q2 | $3.98M | Sell |
296,496
-7,695
| -3% | -$103K | 0.44% | 66 |
|
|
2023
Q1 | $5.04M | Sell |
304,191
-44
| -0% | -$730 | 0.62% | 37 |
|
|
2022
Q4 | $5.66M | Sell |
304,235
-58
| -0% | -$1.08K | 0.72% | 32 |
|
|
2022
Q3 | $3.9M | Sell |
304,293
-222
| -0.1% | -$2.85K | 0.67% | 27 |
|
|
2022
Q2 | $2.14M | Hold |
304,515
| – | – | 0.52% | 39 |
|
|
2022
Q1 | $2.52M | Hold |
304,515
| – | – | 0.51% | 38 |
|
|
2021
Q4 | $2.06M | Hold |
304,515
| – | – | 0.42% | 55 |
|
|
2021
Q3 | $1.61M | Sell |
304,515
-306,592
| -50% | -$1.63M | 0.35% | 72 |
|
|
2021
Q2 | $3.51M | Buy |
611,107
+616
| +0.1% | +$3.54K | 0.63% | 23 |
|
|
2021
Q1 | $2.81M | Buy |
610,491
+234,284
| +62% | +$1.08M | 0.51% | 45 |
|
|
2020
Q4 | $1.26M | Buy |
+376,207
| New | +$1.26M | 0.27% | 121 |
|